Decreased RARγ activity has been implicated in ovarian cancer, and AHPN (CD437), an RARγ agonist, has been shown to induce apoptosis and inhibit growth of ovarian tumor cell lines as well as transplanted tumors in nude mice [34], [35]. This evidence concerns the gene RARG and ovarian neoplasm.